George Hofmeyr to HIV Infections
This is a "connection" page, showing publications George Hofmeyr has written about HIV Infections.
Connection Strength
1,348
-
Effects of injectable contraception with depot medroxyprogesterone acetate or norethisterone enanthate on estradiol levels and menstrual, psychological and behavioral measures relevant to HIV risk: The WHICH randomized trial. PLoS One. 2024; 19(3):e0295764.
Score: 0,251
-
Behavioral effects of different contraceptive methods and HIV acquisition: an ancillary study of the ECHO randomized trial. Reprod Health. 2021 Sep 29; 18(1):192.
Score: 0,211
-
Interpretation, communication, and mechanisms of associations between injectable contraception and HIV risk. Lancet HIV. 2015 Sep; 2(9):e365.
Score: 0,138
-
Hypothesis: amenorrhea-inducing contraception may reduce HIV acquisition risk. Contraception. 2014 Dec; 90(6):615-6.
Score: 0,130
-
Hormonal contraception for women exposed to HIV infection. Cochrane Database Syst Rev. 2014 May 20; (5):CD009741.
Score: 0,127
-
Management of breech presentation in areas with high prevalence of HIV infection. Int J Gynaecol Obstet. 2004 Dec; 87(3):272-6.
Score: 0,066
-
High Levels of Pretreatment HIV-1 Drug Resistance Mutations Among South African Women Who Acquired HIV During a Prospective Study. J Acquir Immune Defic Syndr. 2022 10 01; 91(2):130-137.
Score: 0,055
-
Maternal weight and birth outcomes among women on antiretroviral treatment from conception in a birth surveillance study in Botswana. J Int AIDS Soc. 2021 06; 24(6):e25763.
Score: 0,052
-
Effects of Depot Medroxyprogesterone Acetate, Copper Intrauterine Devices, and Levonorgestrel Implants on Early HIV Disease Progression. AIDS Res Hum Retroviruses. 2020 08; 36(8):632-640.
Score: 0,048
-
Reducing mother-to-child transmission of HIV. S Afr Med J. 2000 Apr; 90(4):322, 324.
Score: 0,048
-
Changes to the World Health Organization guideline on hormonal contraceptive eligibility for women at high risk of HIV: South African perspective and response. S Afr Med J. 2018 Jul 25; 108(8):629-631.
Score: 0,042
-
HIV-1 disease progression in immune-competent HIV-1-infected and breastfeeding mothers participating in the ANRS 12174 clinical trial in Burkina Faso, South Africa, Uganda and Zambia: a cohort study. BMJ Open. 2018 04 05; 8(4):e019239.
Score: 0,041
-
Demographic, clinical and behavioural determinants of HIV serostatus non-disclosure to sex partners among HIV-infected pregnant women in the Eastern Cape, South Africa. PLoS One. 2017; 12(8):e0181730.
Score: 0,040
-
Preventing perinatal infections. BMJ. 1997 Jul 26; 315(7102):199-200.
Score: 0,040
-
Extended pre-exposure prophylaxis with lopinavir-ritonavir versus lamivudine to prevent HIV-1 transmission through breastfeeding up to 50 weeks in infants in Africa (ANRS 12174): a randomised controlled trial. Lancet. 2016 Feb 06; 387(10018):566-573.
Score: 0,035
-
Copper containing intra-uterine devices versus depot progestogens for contraception. Cochrane Database Syst Rev. 2010 Jun 16; (6):CD007043.
Score: 0,024